HKMP.F Stock Overview
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
Hikma Pharmaceuticals PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£22.33 |
| 52 Week High | UK£27.15 |
| 52 Week Low | UK£21.28 |
| Beta | 0.44 |
| 1 Month Change | -4.45% |
| 3 Month Change | -8.95% |
| 1 Year Change | n/a |
| 3 Year Change | -32.86% |
| 5 Year Change | 3.62% |
| Change since IPO | 195.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| HKMP.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -7.9% | -1.5% | -3.2% |
| 1Y | n/a | 9.7% | 19.3% |
Return vs Industry: Insufficient data to determine how HKMP.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how HKMP.F performed against the US Market.
Price Volatility
| HKMP.F volatility | |
|---|---|
| HKMP.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: HKMP.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HKMP.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | 9,100 | Riad Mishlawi | www.hikma.com |
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Hikma Pharmaceuticals PLC Fundamentals Summary
| HKMP.F fundamental statistics | |
|---|---|
| Market cap | US$4.94b |
| Earnings (TTM) | US$190.00m |
| Revenue (TTM) | US$2.88b |
26.0x
P/E Ratio1.7x
P/S RatioIs HKMP.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HKMP.F income statement (TTM) | |
|---|---|
| Revenue | US$2.88b |
| Cost of Revenue | US$1.47b |
| Gross Profit | US$1.41b |
| Other Expenses | US$1.22b |
| Earnings | US$190.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 08, 2024
| Earnings per share (EPS) | 0.86 |
| Gross Margin | 48.94% |
| Net Profit Margin | 6.61% |
| Debt/Equity Ratio | 50.9% |
How did HKMP.F perform over the long term?
See historical performance and comparison